IUPAC/Chemical Name
3-((1-(azepane-1-carbonyl)-2-(naphthalen-2-ylsulfonyl)hydrazinyl)methyl)benzimidamide
InChi Key
CEAMGXQGUYMUIE-UHFFFAOYSA-N
InChi Code
1S/C25H29N5O3S/c26-24(27)22-11-7-8-19(16-22)18-30(25(31)29-14-5-1-2-6-15-29)28-34(32,33)23-13-12-20-9-3-4-10-21(20)17-23/h3-4,7-13,16-17,28H,1-2,5-6,14-15,18H2,(H3,26,27)
SMILES Code
NC(=N)C1=CC(CN(NS(=O)(=O)C2=CC=C3C=CC=CC3=C2)C(=O)N4CCCCCC4)=CC=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
479.60
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Peternel L, Stegnar M, Drevensek G, Budihna MV, Bozic M, Zega A, Stalc A, Cerne M, Urleb U. Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models. Thromb Haemost. 2005 Mar;93(3):437-42. doi: 10.1160/TH04-10-0676. PMID: 15735792.
2: Peternel L, Stempelj M, Cerne M, Zega A, Obreza A, Oblak M, Drevensek G, Budihna MV, Stanovnik L, Urleb U. Direct thrombin inhibitors built on the azaphenylalanine scaffold provoke degranulation of mast cells. Thromb Haemost. 2006 Feb;95(2):294-300. doi: 10.1160/TH05-10-0683. PMID: 16493492.
3: Stempelj M, Zorko M, Peternel L, Urleb U, Ferjan I. Histamine release, an undesired effect of thrombin inhibitors with basic character, is mediated through direct activation of G(i) proteins. Eur J Pharmacol. 2006 May 24;538(1-3):182-7. doi: 10.1016/j.ejphar.2006.03.066. Epub 2006 Apr 4. PMID: 16650405.
